Prevalence of gastrointestinal disorders having an impact on tablet levothyroxine absorption: should this formulation still be considered as the first-line therapy?

ConclusionsThe worldwide prevalence of gastrointestinal disorders associated with tablet LT4 malabsorption, including lactose malabsorption andHelicobacter pylori infection, is high. Interactions with drugs or food can further increase this risk. Considering that all studies investigating the impact of switching patients from tablet to LS or SG found an improved thyroid balance, the latter formulations should be considered as first-line therapy for managing hypothyroidism.
Source: Endocrine - Category: Endocrinology Source Type: research